Table 2 General characteristics of hemodialysis patients (A - before, B - after HD), peritoneal dialysis (PD) treated conservatively (CT) before and after kidney transplantation (TE and TE A) and control group (NK) taking partin the study (mean ± OS)
From: Effect of renal replacement therapy on selected arachidonic acid derivatives concentration
Parameters | HD A | HD B | PD | CT | TE | TE A | NK | P* | P** |
|---|---|---|---|---|---|---|---|---|---|
Kt/V | 1,28 ± 0,21 | – | 2,77 ± 1,06 | – | – | – | – | – | < 0,001 |
Concentrationof creatinine [mg/dl] | 7,9 ± 2,4 | 3,5 ± 1,3 | 4,4 ± 2,2 | 2,5 ± 1,1 | 7,4 ± 3,3 | 3,4 ± 2,9 | 0,8 ± 0,1 | < 0,001 | < 0,001 |
Stage of CKD: | |||||||||
1 | 0 (0%) | – | 0 (0%) | 0 (0%) | 0 (0%) | – | 29 (97%) | – | – |
2 | 0 (0%) | 0 (0%) | 3 (10%) | 0 (0%) | 1 (3%) | NS | NS | ||
3 | 0 (0%) | – | 0 (0%) | 10 (33%) | 0 (0%) | – | 0 (0%) | NS | – |
4 | 0 (0)%) | – | 0 (0%) | 12 (40%) | 0 (0%) | – | 0 (0%) | – | – |
5 | 30 (100%) | – | 31 (100%) | 5 (17%) | 27 (100%) | – | 0 (0%) | – | NS |